As reported earlier in U2OS osteosarcoma cells (Sun et al, 2008), 24 h treatment of HCT116 cells with MPA leads to a dose‐dependent increase in p53 protein levels (Fig 1A). The gene discussed is TP53; the disease is osteosarcoma.